Avidity Partners Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,100,000	Closed	-$42.1M	–	91
2023 Q3	$42.1M	Sell	2,100,000 -234,000	-10%	-$5.94M	1.7%	21
2023 Q2	$65.8M	Sell	2,334,000 -595,300	-20%	-$14.3M	2.3%	11
2023 Q1	$50.4M	Sell	2,929,300 -2,220,700	-43%	-$45M	1.67%	24
2022 Q4	$104M	Buy	5,150,000 +926,900	+22%	+$19.9M	2.42%	15
2022 Q3	$91.5M	Buy	4,223,100 +637,219	+18%	+$17.4M	1.99%	21
2022 Q2	$101M	Buy	3,585,881 +408,882	+13%	+$10.8M	2.31%	19
2022 Q1	$147M	Buy	3,176,999 +461,999	+17%	+$24.9M	3.25%	9
2021 Q4	$228M	Buy	2,715,000 +221,200	+9%	+$17.1M	4.84%	2
2021 Q3	$166M	Buy	2,493,800 +333,800	+15%	+$19.3M	4.24%	7
2021 Q2	$115M	Buy	2,160,000 +896,700	+71%	+$48M	3.11%	7
2021 Q1	$54.8M	Buy	1,263,300 +128,300	+11%	+$5.52M	1.53%	22
2020 Q4	$59M	Buy	1,135,000 +230,881	+26%	+$10.4M	1.98%	14
2020 Q3	$29.6M	Buy	904,119 +229,632	+34%	+$8.04M	1.59%	24
2020 Q2	$32.4M	Buy	+674,487	New	+$25.9M	2.08%	17